Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Pharmaceutical Xinjiang is an operating regional subsidiary of Chongqing Pharmaceutical (Group), focused on pharmaceutical and medical-device distribution in Xinjiang, China. The business is a commercial healthcare company rather than a drug developer, with activities spanning drug wholesale and retail, Class I-III medical device distribution and leasing, Chinese medicine decoction-related services, warehousing, logistics, and healthcare supply-chain services. Public company and registry sources indicate it is an active company headquartered in Urumqi and majority-owned by Chongqing Pharmaceutical (Group) Co., Ltd. The company appears to serve hospitals and other healthcare customers across Xinjiang through distribution, bidding/procurement participation, and cold-chain and storage capabilities. There is no clear evidence that it runs a proprietary therapeutic R&D pipeline; its role is primarily commercial distribution and regional healthcare logistics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Xinjiang Pharmaceutical.